CVS Operating Income vs Interest Expense Analysis
CVS Stock | USD 79.76 0.33 0.42% |
CVS Health financial indicator trend analysis is way more than just evaluating CVS Health Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CVS Health Corp is a good investment. Please check the relationship between CVS Health Operating Income and its Interest Expense accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Operating Income vs Interest Expense
Operating Income vs Interest Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CVS Health Corp Operating Income account and Interest Expense. At this time, the significance of the direction appears to have strong relationship.
The correlation between CVS Health's Operating Income and Interest Expense is 0.68. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Interest Expense in the same time period over historical financial statements of CVS Health Corp, assuming nothing else is changed. The correlation between historical values of CVS Health's Operating Income and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of CVS Health Corp are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Operating Income i.e., CVS Health's Operating Income and Interest Expense go up and down completely randomly.
Correlation Coefficient | 0.68 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Operating Income
Operating Income is the amount of profit realized from CVS Health Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of CVS Health Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Most indicators from CVS Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CVS Health Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. Selling General Administrative is likely to gain to about 45.2 B in 2024, whereas Discontinued Operations is likely to drop (10.9 M) in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Operating Income | 13.2B | 16.3B | 13.7B | 14.4B | Other Operating Expenses | 277.1B | 306.4B | 601.0B | 631.0B |
CVS Health fundamental ratios Correlations
Click cells to compare fundamentals
CVS Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CVS Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 222.4B | 230.7B | 233.0B | 228.3B | 249.7B | 262.2B | |
Short Long Term Debt Total | 89.0B | 85.0B | 76.0B | 70.7B | 79.4B | 83.4B | |
Other Current Liab | 4.8B | 5.8B | 5.6B | 47.6B | 2.5B | 2.3B | |
Total Current Liabilities | 53.3B | 62.0B | 67.8B | 69.7B | 79.2B | 83.1B | |
Total Stockholder Equity | 63.9B | 69.4B | 75.1B | 71.0B | 76.5B | 80.3B | |
Property Plant And Equipment Net | 32.9B | 33.3B | 32.0B | 30.7B | 30.4B | 32.0B | |
Net Debt | 83.3B | 77.2B | 66.6B | 57.8B | 71.2B | 74.7B | |
Retained Earnings | 45.1B | 49.6B | 54.9B | 56.1B | 61.6B | 64.7B | |
Cash | 5.7B | 7.9B | 9.4B | 12.9B | 8.2B | 8.6B | |
Non Current Assets Total | 172.1B | 174.3B | 173.0B | 162.6B | 181.9B | 191.0B | |
Non Currrent Assets Other | 4.6B | 4.6B | 4.7B | 4.0B | 3.6B | 3.8B | |
Cash And Short Term Investments | 8.1B | 10.9B | 12.5B | 15.7B | 11.5B | 12.0B | |
Net Receivables | 19.6B | 21.7B | 24.4B | 27.3B | 35.2B | 37.0B | |
Common Stock Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 984.2M | |
Liabilities And Stockholders Equity | 222.4B | 230.7B | 233.0B | 228.3B | 249.7B | 262.2B | |
Non Current Liabilities Total | 105.0B | 99.0B | 89.8B | 87.2B | 93.9B | 98.6B | |
Inventory | 17.5B | 18.5B | 17.8B | 19.1B | 18.0B | 18.9B | |
Other Current Assets | 5.1B | 5.3B | 5.3B | 2.7B | 3.2B | 3.3B | |
Other Stockholder Equity | (28.2B) | (28.2B) | (28.2B) | (31.9B) | (33.8B) | (32.1B) | |
Total Liab | 158.3B | 161.0B | 157.6B | 157.0B | 173.1B | 181.7B | |
Property Plant And Equipment Gross | 32.9B | 33.3B | 12.9B | 12.9B | 51.1B | 53.7B | |
Total Current Assets | 50.3B | 56.4B | 60.0B | 65.7B | 67.9B | 71.3B | |
Accumulated Other Comprehensive Income | 1.0B | 1.4B | 965M | (1.5B) | (297M) | (311.9M) | |
Short Term Debt | 5.4B | 7.1B | 5.9B | 3.5B | 4.7B | 4.9B | |
Intangible Assets | 33.1B | 31.1B | 29.0B | 24.8B | 29.2B | 30.7B | |
Accounts Payable | 10.5B | 11.1B | 12.5B | 14.8B | 14.9B | 15.6B | |
Common Stock | 46.0B | 46.5B | 47.4B | 48.2B | 49.0B | 51.4B | |
Good Will | 79.7B | 79.6B | 79.1B | 78.2B | 91.3B | 95.8B | |
Common Stock Total Equity | 46.0B | 46.5B | 47.4B | 48.2B | 55.4B | 58.2B | |
Other Liab | 21.4B | 21.0B | 19.7B | 19.9B | 22.9B | 24.1B | |
Other Assets | 9.1B | 51.0B | 9.8B | 7.6B | 8.7B | 4.8B | |
Long Term Debt | 64.7B | 59.2B | 52.0B | 50.5B | 58.6B | 61.6B | |
Treasury Stock | (28.2B) | (28.2B) | (28.2B) | (31.9B) | (28.7B) | (27.2B) | |
Property Plant Equipment | 32.9B | 12.6B | 12.9B | 12.9B | 14.8B | 9.5B | |
Current Deferred Revenue | 32.6B | 38.0B | 43.8B | 3.9B | 57.1B | 60.0B | |
Short Term Investments | 2.4B | 3B | 3.1B | 2.8B | 3.3B | 3.4B | |
Net Tangible Assets | (49.0B) | (41.3B) | (33.1B) | 71.0B | 63.9B | 67.1B | |
Noncontrolling Interest In Consolidated Entity | 318M | 306M | 312M | 300M | 345M | 362.3M | |
Retained Earnings Total Equity | 45.1B | 49.6B | 54.9B | 56.1B | 64.6B | 39.9B | |
Long Term Debt Total | 64.7B | 59.2B | 52.0B | 50.5B | 58.0B | 34.0B |
Pair Trading with CVS Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will appreciate offsetting losses from the drop in the long position's value.Moving against CVS Stock
0.52 | CLVRW | Clever Leaves Holdings | PairCorr |
0.45 | MBIO | Mustang Bio Report 3rd of April 2024 | PairCorr |
The ability to find closely correlated positions to CVS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Health Corp to buy it.
The correlation of CVS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for CVS Stock analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Global Correlations Find global opportunities by holding instruments from different markets |
Is CVS Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Health. If investors know CVS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.10) | Dividend Share 2.42 | Earnings Share 6.47 | Revenue Per Share 277.528 | Quarterly Revenue Growth 0.12 |
The market value of CVS Health Corp is measured differently than its book value, which is the value of CVS that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Health's value that differs from its market value or its book value, called intrinsic value, which is CVS Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Health's market value can be influenced by many factors that don't directly affect CVS Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if CVS Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.